X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2%
Mon, 30 Jul

BIOCON LTD has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

BIOCON LTD Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m9,33711,69511,238-3.9%20.4%
Other incomeRs m5406756881.9%27.4%
TurnoverRs m9,87712,37011,926-3.6%20.7%
ExpensesRs m7,4169,3658,860-5.4%19.5%
Gross profitRs m1,9212,3812,378-0.1%23.8%
DepreciationRs m9889539914.0%0.3%
InterestRs m1611691764.1%9.3%
Profit before taxRs m1,3121,9341,899-1.8%44.7%
TaxRs m37640752128.0%38.6%
Profit after taxRs m9361,5271,378-9.8%47.2%
Gross profit margin%20.620.421.2
Effective tax rate%28.721.027.4
Net profit margin%9.512.311.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 20.4% on a year-on-year (YoY) basis. The expenses were up by 19.5% YoY during the same period.
  • The company's operating profit increased by 23.8% YoY during the quarter. Consequently, operating profit margins remained same and stood at 21.2% in 1QFY19.
  • Depreciation charges and finance costs increased by 0.3% YoY and 9.3% YoY, respectively.
  • Other income increased by 27.4% YoY during the quarter.
  • Net profit for the quarter increased by 47.2% YoY. Net profit margins during the quarter increased from 9.5% in 1QFY18 to 11.6% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 3.9% on a quarter-on-quarter (QoQ) basis. The expenses were down by 5.4% QoQ during the same period.
  • The company's operating profit increased by 0.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 21.2% in 1QFY19 as against 20.4% in 4QFY18.
  • Net profit for the quarter declined by 9.8% QoQ, while net profit margins declined from 12.3% in 4QFY18 to 11.6% in 1QFY19.

To see how BIOCON LTD has performed over the last eight quarters, please visit here.

BIOCON LTD Share Price Performance

Over the last one year, BIOCON LTD share price has moved up from Rs 390.2 to Rs 581.2, registering a Gain of Rs 191.1 or around 49.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,122.7 (up 0.7%). Over the last one year it has moved down from 14,414.2 to 14,122.7, a gain of 291 points (down 2.0%).

Overall, the S&P BSE SENSEX is up 0.4% over the year.

Current Valuations

At the current price of Rs 581.2, the price to earnings (P/E) ratio of BIOCON LTD stands at 79.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.7 times.

Equitymaster requests your view! Post a comment on "BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2%". Click here!

  

Related Views on News

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 19.8% YoY). Sales on the other hand came in at Rs 12 bn (up 25.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Nov 12, 2018 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD - ASTRAZENECA PHARMA COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS